← Leaderboards
Frank Markus
Brigham And Women'S Hospital
$1,251,656
Attributed
$1,251,656
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $273.2K · FY2008–12$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,251,656 · 1
By mechanism
P50$1,251,656 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Tobias Schatton$4,457,299
- Charles J Dimitroff$9,730,798
- Charles S Fuchs$37,354,862
- Markus H. Frank$10,452,698
- Steven Russell Barthel$2,531,097
Others in their field
Top investigators on “Xenograft Procedure”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,763,818
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Peter J Houghton · University Of Texas Hlth Science Center$20,565,889
- Connie Suders · Leidos Biomedical Research, Inc.$19,812,417
- David H Sachs · Columbia University Health Sciences$18,932,200
Research focus
Xenograft ProcedureAnimal ModelBenign Melanocytic NevusTherapeutic Clinical TrialTherapeutic TargetTissue MicroarrayTreatment EfficacyTumorigenicTumor InitiationAblationCellsChemotherapyClinically RelevantDoxorubicinFundingGrowthIn VitroIn VivoMelanomaMelanoma CellMulti-Drug ResistanceNeoplastic CellPhenotypePrimary Lesion
Grant awards (5)
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting$232,504
P50 · FY2012 · CA · contact PI
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting$264,624
P50 · FY2011 · CA · contact PI
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting$273,199
P50 · FY2010 · CA · contact PI
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting$271,866
P50 · FY2009 · CA · contact PI
ABCB5 and Melanoma Stem Cells: Implications for Prognosis & Therapeutic Targeting$209,463
P50 · FY2008 · CA · contact PI